The Global Vitamin B12 Market was valued at USD 760 million in 2025 and is estimated to grow at a CAGR of 6.8% to reach USD 1.5 billion by 2035.
The market is witnessing expansion driven by rising demand across dietary supplements, food fortification, pharmaceutical formulations, and animal nutrition applications. Structural growth is being supported by multiple long-term factors, including the increasing shift toward plant-based diets, a growing elderly population experiencing reduced nutrient absorption, and stronger regulatory emphasis on mandatory food fortification in developing regions. A key transformation shaping the market is the growing differentiation between high-volume standard Vitamin B12 types and premium-grade formulations, which is influencing pricing structures, product positioning, and end-user segmentation across global supply chains. Consumer behavior is also shifting toward functional nutrition products that offer added health benefits such as improved energy levels, cognitive support, and immune system enhancement. Vitamin B12 remains one of the most technically complex vitamins to manufacture at scale, requiring advanced microbial fermentation processes conducted under controlled anaerobic environments using specialized bacterial strains. These evolving production dynamics, combined with rising health awareness and expanding application scope, continue to strengthen long-term demand across the global Vitamin B12 industry.
The cyanocobalamin segment held 52% share in 2025. This dominance is attributed to its cost efficiency, widespread regulatory acceptance, and suitability for large-scale incorporation into food and pharmaceutical products. The compound is widely used due to its stable formulation characteristics and its approval across multiple regulatory frameworks, enabling manufacturers to maintain compliance while achieving cost-effective production at scale for global distribution.
North America Vitamin B12 Market held 27% share in 2025 and is projected to grow at a CAGR of 6.5% through 2035. The region continues to show strong demand supported by high supplement consumption rates and increasing awareness of preventive healthcare. The United States remains the leading contributor in the region, driven by widespread dietary supplement usage and strong consumer preference for vitamin-enriched products that support daily nutritional requirements.
Major companies operating in the Global Vitamin B12 Market include DSM-Firmenich, BASF SE, EUROAPI, Spectrum Chemical Mfg. Corp., Fagron, Merck KGaA, CSPC Pharmaceutical Group, Ningxia Kingvit Pharmaceutical, Rochem International Inc., Loba Chemie Pvt. Ltd., Farbest Brands, Hebei Yuxing Bio-Engineering Co., Ltd., and NOW Foods. Companies operating in the Vitamin B12 market are focusing on strengthening their market position through expansion of fermentation-based production capacities and continuous optimization of microbial synthesis processes. Manufacturers are investing heavily in research and development to improve yield efficiency, product purity, and cost competitiveness. Strategic partnerships with pharmaceutical firms, nutraceutical brands, and food manufacturers are enabling broader application development and stronger distribution networks. Companies are also prioritizing regulatory compliance across multiple regions to facilitate global market access. In addition, investments in premium formulations such as high-bioavailability and specialized delivery formats are helping firms differentiate their product portfolios.
This product will be delivered within 2-4 business days.
The market is witnessing expansion driven by rising demand across dietary supplements, food fortification, pharmaceutical formulations, and animal nutrition applications. Structural growth is being supported by multiple long-term factors, including the increasing shift toward plant-based diets, a growing elderly population experiencing reduced nutrient absorption, and stronger regulatory emphasis on mandatory food fortification in developing regions. A key transformation shaping the market is the growing differentiation between high-volume standard Vitamin B12 types and premium-grade formulations, which is influencing pricing structures, product positioning, and end-user segmentation across global supply chains. Consumer behavior is also shifting toward functional nutrition products that offer added health benefits such as improved energy levels, cognitive support, and immune system enhancement. Vitamin B12 remains one of the most technically complex vitamins to manufacture at scale, requiring advanced microbial fermentation processes conducted under controlled anaerobic environments using specialized bacterial strains. These evolving production dynamics, combined with rising health awareness and expanding application scope, continue to strengthen long-term demand across the global Vitamin B12 industry.
The cyanocobalamin segment held 52% share in 2025. This dominance is attributed to its cost efficiency, widespread regulatory acceptance, and suitability for large-scale incorporation into food and pharmaceutical products. The compound is widely used due to its stable formulation characteristics and its approval across multiple regulatory frameworks, enabling manufacturers to maintain compliance while achieving cost-effective production at scale for global distribution.
North America Vitamin B12 Market held 27% share in 2025 and is projected to grow at a CAGR of 6.5% through 2035. The region continues to show strong demand supported by high supplement consumption rates and increasing awareness of preventive healthcare. The United States remains the leading contributor in the region, driven by widespread dietary supplement usage and strong consumer preference for vitamin-enriched products that support daily nutritional requirements.
Major companies operating in the Global Vitamin B12 Market include DSM-Firmenich, BASF SE, EUROAPI, Spectrum Chemical Mfg. Corp., Fagron, Merck KGaA, CSPC Pharmaceutical Group, Ningxia Kingvit Pharmaceutical, Rochem International Inc., Loba Chemie Pvt. Ltd., Farbest Brands, Hebei Yuxing Bio-Engineering Co., Ltd., and NOW Foods. Companies operating in the Vitamin B12 market are focusing on strengthening their market position through expansion of fermentation-based production capacities and continuous optimization of microbial synthesis processes. Manufacturers are investing heavily in research and development to improve yield efficiency, product purity, and cost competitiveness. Strategic partnerships with pharmaceutical firms, nutraceutical brands, and food manufacturers are enabling broader application development and stronger distribution networks. Companies are also prioritizing regulatory compliance across multiple regions to facilitate global market access. In addition, investments in premium formulations such as high-bioavailability and specialized delivery formats are helping firms differentiate their product portfolios.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by type, 2022-2035 (USD Million) (Kilo Tons)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 (USD Million) (Kilo Tons)
Chapter 7 Market Estimates and Forecast, by Distribution Channel, 2022-2035 (USD Million) (Kilo Tons)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 (USD Million) (Kilo Tons)
Chapter 9 Company Profiles
Companies Mentioned
- DSM-Firmenich
- BASF SE
- EUROAPI
- Spectrum Chemical Mfg. Corp.
- Fagron
- Merck KGaA
- CSPC Pharmaceutical Group
- Ningxia Kingvit Pharmaceutical
- Rochem International Inc.
- Loba Chemie Pvt. Ltd.
- Farbest Brands
- Hebei Yuxing Bio-Engineering Co., Ltd.
- NOW Foods
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 124 |
| Published | July 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 760 Million |
| Forecasted Market Value ( USD | $ 1500 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
